Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
PDZ-binding kinase (PBK) is known to regulate tumor progression in some cancer types. However, its relationship to immune cell infiltration and prognosis in different cancers is unclear. This was investigated in the present study by analyzing data from TCGA, GEO, GETx, TIMER, CPTAC, GEPIA2, cBioPort...
Guardado en:
Autores principales: | Yi Liu, Juan Xiang, Gang Peng, Chenfu Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/00465ef15902467e8cb237ff2869f634 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An Integrative Pan-Cancer Analysis of PBK in Human Tumors
por: Huantao Wen, et al.
Publicado: (2021) -
Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1)
por: Shuang Gao, et al.
Publicado: (2021) -
Prognostic and immunological value of LTB4R in pan-cancer
por: Sidan Long, et al.
Publicado: (2021) -
PPP1R14B Is a Prognostic and Immunological Biomarker in Pan-Cancer
por: Mingxia Deng, et al.
Publicado: (2021) -
MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Xiaoyu Zhang, et al.
Publicado: (2021)